What Has Been the Progress and Growth of the Mucosal Atomization Devices Market in Recent Years?
The mucosal atomization devices market has seen considerable growth due to a variety of factors.
• Recent years have seen substantial growth in the mucosal atomization devices market size. The market, which was valued at $0.85 billion in 2024, is projected to elevate to $0.92 billion by 2025, illustrating a compound annual growth rate (CAGR) of 9.1%.
This considerable rise during the past years is a result of applications in emergency medicine, anesthesia, pediatric care, pain management, and dental procedures.
What Can Be Expected from the Mucosal Atomization Devices Market in the Coming Years?
The mucosal atomization devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the following years, the market for mucosal atomization devices is projected to expand quickly. The value is set to reach $1.4 billion by 2029, with a compound annual growth rate (CAGR) of 10.9%.
This upward trend during the forecast period can be linked to factors such as chronic illness, telemedicine, precision medicine, cosmetic procedures, patient comfort, and autonomous vehicles. The forecast period will also feature key trends like sustainable and eco-friendly practices, digital management of mortuaries, greener burial alternatives, remote viewing and streaming services, as well as hybrid funeral services.
What Are The Leading Drivers Of Growth In The Mucosal Atomization Devices Market?
The global rise in allergic rhinitis cases is fueling the expansion of the mucosal atomization devices market. Allergic rhinitis, caused by inhalation of allergens such as dust, animal dander, or pollen, triggers a set of nasal symptoms. To treat chronic rhinosinusitis, mucosal atomization devices are employed to administer budesonide, a topical nasal steroid spray. The Allergy Capital Report 2022 reveals that seasonal allergic rhinitis, also known as hay fever, is one of the most prevalent allergic conditions. In the United States, about 7.7% of adults and 7.2% of children are diagnosed with seasonal allergic rhinitis. Hence, the global surge in allergic rhinitis cases is escalating the demand for mucosal atomization devices market.
How Are The Segments Defined Within The Global Mucosal Atomization Devices Market?
The mucosal atomization devices market covered in this report is segmented –
1) By Type: Nasal Atomization Devices, Fiber-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices, Bottle Atomizer Devices
2) By Technology: Gas Propelled Atomization Devices, Electrical Atomization Devices
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics
Subsegments:
1) By Nasal Atomization Devices: Handheld Nasal Sprays, Mechanical Nasal Atomizers, Electric Nasal Atomizers
2) By Fiber-Optic Atomization Devices: Portable Fiber-Optic Atomizers, Fixed Fiber-Optic Atomizers, Single-Use Fiber-Optic Atomizers
3) By Laryngo-Tracheal Atomization Devices: Jet Nebulizers, Ultrasonic Nebulizers, Portable Laryngo-Tracheal Atomizers
4) By Bottle Atomizer Devices: Manual Bottle Atomizers, Pressurized Bottle Atomizers, Plastic Bottle Atomizers
Pre-Book The Mucosal Atomization Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Mucosal Atomization Devices Market?
Leading firms in the mortuary equipment market are pursuing a strategy of strategic alliances to advance the development of nasal powder delivery device technology. This refers to a scenario where companies utilize each other's expertise and assets to attain mutual growth and success. For instance, in November 2023, Hovione, a company headquartered in Portugal that provides developmental and manufacturing services for pharmaceutical drugs, formed an alliance with Industrial Design Consultancy (IDC), a UK-based company specializing in product design and development. The objective of this collaboration is to develop a novel nasal powder delivery device technology that enables local, systemic, and nose-to-brain drug administration. These tools are intended to provide wide-ranging and specific nasal deposition flexibility, securing optimal usability and dependability.
Who Are the Key Players in the Mucosal Atomization Devices Market?
Major companies operating in the mucosal atomization devices market include:
• Teleflex Incorporated
• DeVilbiss Healthcare LLC
• Becton Dickinson and Company
• Cook Medical LLC
• Medica Holdings LLC
• Life-Assist Inc.
• Pulmodyne Inc.
• Alcove Manufacturing and Distribution Inc.
• LMA North America Inc.
• Medline Industries Inc.
• Medtronic plc
• Smiths Medical Inc.
• Vyaire Medical Inc.
• Westmed Inc.
• Mercury Medical
• SunMed LLC
• Salter Labs
• Armstrong Medical Industries Inc.
• VBM Medizintechnik GmbH
• Intersurgical Ltd.
• Flexicare Medical Limited
• Medovations Inc.
• Medisize BV
• Atom Medical Corporation
• BLS Systems Limited
• Central Admixture Pharmacy Services Inc.
• Dali Medical Devices Co. Ltd.
• Dynarex Corporation
What Is The Most Dominant Region In The Mucosal Atomization Devices Market?
North America was the largest region in the mucosal atomization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
